Answers are grounded in this paper and cite their sources.
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, often complicated by therapeutic resistance and tumor heterogeneity. The JAK/STAT signaling pathway plays a pivotal role in converting extracellular signals into diverse cellular responses. Here, we provide a comprehensive overview of the canonical JAK/STAT cascade and its intrinsic regulatory mechanisms. Specifically, we explore how aberrant JAK/STAT signaling drives HCC progression by regulating epithelialmesenchymal transition, facilitating tumor immune evasion, mediating drug resistance, and modulating ferroptosis. Finally, we highlight current translational challenges and summarize emerging therapeutic strategies, including AI-assisted design and PROTACs, aiming to offer new insights into biomarker-guided targeted interventions for HCC.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: